Advertisement
Home »

Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating Scale.

Jan 09, 2023

ABOUT THE CONTRIBUTORS

  • Qian Zhao

    Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan 030001, China.

    Yan Wang

    Hepatobiliary and Pancreatic Surgery and Liver Transplantation Center, First Hospital of Shanxi Medical University, Taiyuan 030001, China.

    Tianyu Huo

    Hepatobiliary and Pancreatic Surgery and Liver Transplantation Center, First Hospital of Shanxi Medical University, Taiyuan 030001, China.

    Furong Li

    Department of Pathology & Pathophysiology, School of Basic Medicine Shanxi Medical University, Taiyuan 030001, China.

    Lu Zhou

    Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan 030001, China.

    Yongliang Feng

    Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan 030001, China.

    Zhigang Wei

    Hepatobiliary and Pancreatic Surgery and Liver Transplantation Center, First Hospital of Shanxi Medical University, Taiyuan 030001, China.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement